Tema ETFs’s Oric Pharmaceuticals ORIC Stock Holding History

Tema ETFs’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$628K	Buy	57,977 +750	+1%	+$6.8K	0.02%	370
2026 Q1	$725K	Buy	57,227 +29,373	+105%	+$333K	0.05%	291
2025 Q4	$228K	Buy	+27,854	New	+$321K	0.02%	475
2025 Q2	–	Sell	-40,934	Closed	-$228K	–	171
2025 Q1	$228K	Sell	40,934 -4,542	-10%	-$39.7K	0.07%	138
2024 Q4	$367K	Buy	+45,476	New	+$417K	0.15%	120

Other funds holding ORIC

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Tema ETFs's ORIC Position: Q2 2026 in Review

Tema ETFs increased its Oric Pharmaceuticals (ORIC) stake by 1.3% in Q2 2026, buying an estimated $6.8K and bringing the position to 57,977 shares worth $628K. The position accounts for 0.02% of the portfolio, ranked #370.

Tema ETFs first reported a position in ORIC in Q4 2024 and has held it in 5 quarters since. The position peaked at $725K in Q1 2026. 6 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

Tema ETFs held 57,977 shares of Oric Pharmaceuticals worth $628K as of Q2 2026.
Tema ETFs bought 750 Oric Pharmaceuticals shares in Q2 2026, an estimated $6.8K.
Oric Pharmaceuticals made up 0.02% of Tema ETFs's portfolio in Q2 2026, its #370 holding.
Tema ETFs first reported a position in Oric Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
Tema ETFs's Oric Pharmaceuticals position peaked at $725K in Q1 2026.
6 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.